• Users Online: 293
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login 
ORIGINAL ARTICLE
Year : 2009  |  Volume : 1  |  Issue : 1  |  Page : 7-15

Even a single, remotely positive post-transplant alloantibody test correlates with increased chronic allograft nephropathy and graft loss after kidney transplantation


1 Comprehensive Transplant Center, The Ohio State University Medical Centers, Columbus, Ohio, USA
2 Division of Biostatistics, The Ohio State University College of Public Health, Columbus, Ohio, USA

Correspondence Address:
Ronald P Pelletier
Comprehensive Transplant Center, The Ohio State University Medical Centers, Columbus, Ohio
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1947-489X.211051

Rights and Permissions

Background: Chronic renal allograft loss is considered as immunologically mediated when donor-specific alloantibodies are detected. However, remotely detected alloantibodies with lack of detection more proximate to graft loss occurrence may obscure the humoral association with graft damage. Methods: We retrospectively reviewed 609 patients multiply tested post-transplant for detectable alloantibodies and correlated their results with clinical outcomes. Results: Most patients had no detectable post-transplant alloantibodies (Group 1, n = 393), some converted from nondetectable to detectable alloantibodies (Group 2, n = 97), some always had detectable post-transplant alloantibodies (Group 3, n = 69), and some demonstrated alloantibodies that subsequently became undetectable (Group 4, n = 50). The incidence of death-censored graft survival for Group 4 patients was similar to Group 2 and 3 patients, and greater than Group 1 patients. Further, interstitial fibrosis/tubularatrophy (IF/TA) free survival was significantly worse (p=0.018) for Group 4 versus Group 1 recipients. Also, Group 4 versus Group 1 IF/TA-free survival was worse when recipients were regrouped based solely on anti-HLA class II (p=0.006), but not anti-HLA class I (p=ns) antibodies. Conclusions: Detectable anti-HLA antibodies, even remotely, post-transplant identifies recipients at greater risk for IF/TA associated graft loss when compared to patients without detectable alloantibodies.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed373    
    Printed36    
    Emailed0    
    PDF Downloaded50    
    Comments [Add]    

Recommend this journal